Statistics
Publications
2
Citations
29
H-Index
2
Active since
2022
C.H.H. Ottensmeier is an author at BioNTech (Germany) specializing in vaccine-based immunotherapy, pembrolizumab therapy, and immunotherapy.
Publications per year
2022–2024
2
2
Nabil F. Saba, K. Klinghammer, E. Castelluci et al. · Annals of Oncology · 2024 · 12 citations · Full text
Medicine, Immunology, Oncology +17
1–2 of 2